Literature DB >> 12093492

LC determination of YM466, a new factor Xa inhibitor, in rat and dog plasma.

Yuji Mano1, Toshiko Aoki, Yumiko Kikuchi, Yoshiaki Soeishi, Takashi Usui, Hidetaka Kamimura.   

Abstract

A specific method for the determination of YM466, a novel Factor Xa inhibitor, in rat and dog plasma was developed and validated. YM466 was extracted from plasma by solid-phase extraction and analyzed by UV-HPLC at an absorbance wavelength of 240 nm. The intra-day precision and accuracy ranged from 0.8 to 2.4% and 0.1 to 5.0% in rats, and from 1.6 to 2.4% and 0.0 to 4.1% in dogs, respectively. The lower limit of quantification was 10 ng/ml when 1 ml of plasma was used. No endogenous interference was observed in the plasma of rats and dogs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093492     DOI: 10.1016/s0731-7085(02)00103-6

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Pharmacokinetics of YM466, a new factor Xa inhibitor, in rats and dogs.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jan-Mar       Impact factor: 2.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.